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Background: In-room cone-beam computerized tomography (CBCT) imaging is a promising method to reduce
setup errors, especially in organs such as the bladder that often have large intrafractional variations due to organ
movement. CBCT image quality is limited by low contrast and imaging artifacts, but few data have been reported
about inter-observer variability of bladder boundary delineation on CBCT. The aim of this work was to analyze and
evaluate the inter-observer contouring uncertainties of bladder boundary delineation on CBCT images in a
prospective fashion.
Methods: Five radiation oncologists contoured 10 bladders using the CBCT datasets of consecutive 10 patients
(including 4 females) who were irradiated to the pelvic region. Prostates were also contoured in male patients.
Patients who had had prostatectomy were excluded. The coefficient of variation (COV), conformity index (CIgen),
and coordinates of center-of-mass (COM) of the bladder and prostate were calculated for each patient.
Results: The mean COV for the bladder and prostate was 0.08 and 0.20, respectively. The mean CIgen of the bladder
and prostate was 0.81 and 0.66, respectively. The root mean square (RMS) of the inter-observer standard deviation
(σ) of the COM displacement in the left-right (LR) and anterior-posterior (AP) direction was 0.79, 0.87 and 0.54 for
the bladder and 0.63, 0.99 and 1.72 for the prostate. Regarding the mean COV and CIgen for the bladder, the
differences between males and females were not significant.
Conclusions: Inter-observer variability for bladder delineation on CBCT images was substantially small regardless of
gender. We believe that our results support the applicability of CBCT in adaptive radiotherapy for bladder cancer.
Keywords: Bladder cancer, Image guided radiotherapy, Cone beam CT, Inter-observer variabilityBackground
The bladder continually changes volume and position on
a daily basis, and as a result, treating a bladder typically
requires at least a 1.5- to 2-cm isotropic setup margin in
radiotherapy [1,2]. Such a large margin and treatment
field may result in late bladder and bowel toxicity [3,4].
Conformal irradiation of the bladder may reduce these
complication risks.
Recently, various kinds of image-guidance technology,
such as implanted fiducial markers, on-board kilovoltage
cone-beam computed tomography (CBCT), and ultra-
sonograpy, are widely used [5,6]. We had previously
reported the efficacy of implanted fiducial markers in* Correspondence: sshing@med.hokudai.ac.jp
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reproduction in any medium, provided the orreducing uncertainty due to setup error and internal organ
motion [7,8], but implantation is an invasive procedure,
and fiducial markers are themselves surrogates for
implanted organ position and provide no information
on organ deformation or volume.
Of the other image-guidance technologies, CBCT is less
invasive and the most common image-guided radiation
therapy (IGRT) method, providing the volumetric-anatomic
information and the opportunity to localize target volumes
in a few minutes before each treatment fraction. Daily
online adaptive radiotherapy using pre-planned treatment
plans and CBCT has received much attention for its
ability to reduce setup error and the required margins,
thereby reducing the dose to the bowel in external beam
radiotherapy for bladder cancer [9-13]. However, CBCT
images have been qualitatively described as inferior tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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uncertainty in delineating organ boundaries described
in previous studies [14,15].
Regarding delineating bladder boundaries on planning
CT images, it was reported that the inter-observer variation
was relatively small [16,17], but few data are available
about inter-observer variation on CBCT images. Most of
the available data were reported in prostate cancer patients
in a retrospective fashion, and the bladder was contoured
as an organ at risk. These data could contain patient
selection bias and gender bias, because some preparation
protocols were applied to most of the prostate cancer
patients and these patients were inevitably male. The
bowel and bladder preparation protocol, such as voiding
and collecting urine, defecating before treatment and
endorectal balloon, is used to reduce factors of influence
in interfraction motion, but these procedure may affect
the delineation of the bladder on CBCT images. Moreover,
the effect of organs peculiar to women (e.g., uterus and
ovaries) in detecting organ boundaries with CBCT images
was not considered.
To study image-guided radiotherapy for bladder can-
cer using CBCT, we conducted a prospective contouring
protocol to analyze and evaluate the inter-observer
contouring uncertainties of bladder boundary delineation
on CBCT images with minimal preparation. We also
analyzed the inter-observer contouring uncertainties of
the prostate as the benchmark to link with previously
published studies.
Methods
Patients’ and observers’ characteristics
Since April 2011, ten consecutive patients who were irradi-
ated to the pelvic region were enrolled in this multiple-
observer contouring study. The ethical committee of
Hokkaido University Hospital approved this study (number
010-0305). Patients who had had prostatectomy were
excluded. The individual patients’ characteristics are
listed in Table 1. Of the five patients with bladder tumors,Table 1 Patient characteristics
Patient Age Gender Tumor site
A 90 Female Bladder
B 70 Female Uterus
C 83 Female Bladder
D 71 Female Bladder
E 68 Male Prostate
F 83 Male Bladder
G 90 Male Bladder
H 77 Male Prostate
I 69 Male Prostate
J 74 Male Prostatetwo patients received ureteral stents prior to radiotherapy.
Fiducial markers were not placed in any of the patients.
Five physicians (four experienced radiation oncologists
and one senior resident of the Department of Radiation
Oncology who had worked in genito-urinary service)
were recruited for the study (KN, RK, TI, SO, KY, and KH).
The clinical experience of radiotherapy of all observers
was ranged from 3 to 8 years with an average experience
of 5.6 years.
CBCT image acquisition
Patients with bladder cancer were asked to void just
before their treatment during the treatment course, and
no other bowel or bladder preparation protocol including
diet-related instruction was offered to any of the 10
patients. All CBCT datasets were acquired weekly in
the supine position, immediately after initial setup to skin
marks. CBCT images were not used to adjust the patient’s
position in this study period.
All patients were imaged and treated on a Varian Clinac
iX Linear Accelerator (Varian Medical Systems, Palo Alto,
CA, USA) using the kV imaging system. The CBCT
images were acquired using standard factory settings
of 125 kVp, 80 mA, and 20 ms per projection with a
half bow-tie filter. Images were reconstructed at an axial
slice thickness of 0.25 cm.
Contouring protocol
For delineation of the organ boundaries, we used the
first CBCT dataset of each patient that contained the entire
bladder and prostate during the treatment course.
All observers were asked to delineate the outer contour
of the whole bladder and prostate without margin for
microscopic extension and seminal vesicles. In all cases
the bladder was contoured as a solid organ. Contouring
was performed in a blinded fashion, i.e., each observer
could use only one image dataset of the patient at the time
of delineation. Access to the structures drawn by other
participants or the other imaging modalities (e.g., treat-
ment planning CT, diagnostic CT, or MRI) as well as the
help of a radiologist was not permitted. Contouring was
carried out in the treatment planning system (Eclipse ver.
8.9, Varian Medical Systems, Inc.) using the standard tools
available. Observers were free to modify window range
and level of the images as preferred, and interpolation of
the contours between slices was allowed. Intra-observer
error was not investigated as part of this study.
Inter-observer variation analysis
The total encompassing delineated volume and the over-
lapping volume between the observers’ contours were
calculated using the Eclipse planning system Boolean
function.
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we calculated coefficients of variation (COV = standard
deviation/mean volume) for the bladder and prostate.
The COVs of all observers’ contours per patient were
calculated and averaged over all patients.
To evaluate the inter-observer concordance, the gener-
alized conformity index (CIgen), defined as the ratio of the
sum of all overlapping volumes between pairs of observers
and the sum of all overlapping and all non-overlapping
volumes between the same pairs [18], was used, as follows:
CIgen ¼
Xn
i; j¼1 pairs V i∩V j
 
Xn
i; j¼i pairs V i∪V j
  ;
A CIgen of 1 indicates 100% concordance for the volume
segmentation, a CIgen of 0.5 indicates 50% agreement
between observers for the encompassing volume, a CIgen
of 0 indicates no concordance in delineation. The CIgens
were calculated per patient and averaged over all patients.
Coordinates of the center-of-mass (COM) of each
structure in 3D were also extracted. COM displacement
values along the left-right (LR), anterior-posterior (AP),
and cranial-caudal (CC) direction were analyzed. As the
overall mean of standard deviation, the root mean square
(RMS) of the total COM standard deviation (σ) on CBCT
was calculated, as follows:
σ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ




where σi indicates the standard deviation of the COM
displacement value of the structure in patient i drawn by
the respective observer in a given direction.
To evaluate the reliability of this study, we calculated
the intra-class correlation coefficients (ICC(2,k)), where
k represents the number of observers. The ICC is a tool







where the subscripts ws and bs denote within-subject
and between-subjects variance, respectively. As the true
value of the variance is unknown, we use estimates from
analysis of variance (ANOVA) analysis, which provides
the variance components with respective mean squares
between patient cases (MSbpat), within one patient case
(MSwpat), between observers (MSobs), and between error
terms (MSerr). As different forms of ICC are described in
the literature, we selected ICC(2,k) for the situation in
which some physicians (observers) of the departmentdelineated organ boundaries in multiple patients, once
for each patient. The ICC can be used to assess the
overall reliability of k observers in contouring all n given
cases (ICC(2,k)), as follows:
ICC 2; kð Þ ¼ MSbpat−MSerr
MSbpat þ MSobs−MSerrn
ICC values < 0.4 indicate poor reliability, ICC values
between 0.4 and 0.6 indicate moderate reliability, and
ICC values > 0.6 or 0.8 denote substantial or excellent
reliability, respectively [19].
Statistical analysis was performed with JMP 9.0.3
(SAS Institute, Cary, NC, USA) and SPSS 11.5 (SPSS
Inc., Chicago IL). Statistical significance of the outcome
was assumed for p<0.05.
Results
All observers were able to contour both the bladder and
the prostate using the CBCT images. Figure 1 shows the
variation between observers for a male patient and a female
patient. The mean contoured volume (range of standard
deviation of the volume) of the bladder for all patients
was 32.4-204.0 cm3 (2.1-17.2 cm3). For the male patient,
the mean volume of the prostate was 19.6-111.9 cm3
(4.0-7.9 cm3).
The average ICC(2,k) values of observers for the bladder
was 0.9954. When separated by gender, the average ICC
(2,k) values for male and female bladder was 0.9980 and
0.9873, respectively. This suggests correlation between
the observers in both gender. The average ICC(2,k)
values for the prostate was 0.9950.
COV
The mean COV (± standard error of the mean) of the
bladder and prostate was 0.08 (± 0.01) and 0.20 (± 0.04),
respectively. Data of individual patients are shown in
Table 2. The difference of COV between the bladder and
prostate was statistically significant (p=0.0442). Regarding
the mean bladder COV between the male patient and
the female patient, the difference was not significant
(0.07 for the male, 0.08 for the female, p=0.7745).
CIgen
The mean CIgen (± standard error of the mean) of the
bladder and prostate was 0.81 (± 0.02) and 0.66 (± 0.03),
respectively (Figure 2). The difference of mean CIgen
between the bladder and prostate was statistically
significant (p=0.0038). The difference of mean blad-
der CIgen between the male patient and the female
patient was not significant (0.80 for the male, 0.82 for the
female, p=0.7099).
Figure 1 Example of organ boundary delineation in a male and a female. The two leftmost and two rightmost images are transaxial (upper)
and sagittal (lower) images through the center of the bladder of patient H (male) and patient C (female), respectively.
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The RMS of the standard deviation (σ) of the inter-observer
COM displacement was 0.79, 0.87, and 0.54 for the blad-
der and 0.63, 0.99, and 1.72 for the prostate in the LR, AP,
and CC direction, respectively (Figure 3). Regarding the
COM location for the bladder in terms of gender, σ was
0.89, 1.00, and 0.41 for males and 0.60, 0.64, and 0.68 for
females in the LR, AP, and CC direction, respectively.
Discussion
CBCT is an established strategy for 3D image guidance
during treatment. It provides reasonable soft-tissue contrast
and enables the verification of both target volume and
organ at risk displacements. Prostate cancer is one of theTable 2 Patient-specific results of volumes and COV
Patient Gender Bladder volume (cm3)
Mean Range SD
A Female 103.2 94.4-111.4 6.5
B Female 71.3 68.5-74.2 2.1
C Female 82.7 67.7-96.4 10.6
D Female 166.1 147.4-193.2 17.2
E Male 83.4 76.0-87.8 5.2
F Male 46.5 43.7-48.9 2.1
G Male 204.0 195.4-222.6 10.9
H Male 123.2 120.6-129.7 3.7
I Male 32.4 25.2-41.6 6.0
J Male 172.1 158.6-182.7 8.9
Abbreviations: SD Standard deviation, COV Coefficients of variation.most frequently targeted tumors using CBCT, and many
studies have reported its efficacy [20,21]. The authors
of some of these studies reported that the accuracy of
kilovoltage CBCT was similar to that of kV fiducial
imaging for prostate patients with implanted gold fiducial
markers [22,23], but the subjective CBCT image quality
was worse compared with that of diagnostic CT or MRI
[14] and large inter-observer variability in organ boundary
delineation was expected.
CBCT has been found to be useful, especially in organs
expected to have large intrafractional error due to organ
movement, such as the bladder, but up to now few data
have been available about the accuracy of bladder
delineation by CBCT. Foroudi et al. reported 4 patientsCOV Prostate volume (cm3) COV
Mean Range SD
0.06 - - - -
0.03 - - - -
0.13 - - - -
0.10 - - - -
0.06 20.7 14.3-32.2 6.8 0.33
0.05 25.6 16.5-37.9 7.9 0.31
0.05 19.6 14.1-25.8 4.2 0.21
0.03 31.6 27.2-37.0 4.0 0.13
0.18 32.9 28.8-41.5 5.3 0.16
0.05 111.9 106.0-116.9 4.1 0.04
Figure 2 Generalized conformity index (CIgen) for the study patients. The horizontal blue solid line indicates the mean of the overall CIgens
of ten bladders (0.81), and the blue dotted line and blue dashed line indicate the mean of the CIgens of the female bladders (0.82) and male
bladders (0.80), respectively. The red solid line indicates the mean of overall CIgens of prostates (0.66).
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CBCT was not significantly inferior to that of conven-
tional planning CT in the contouring of the whole bladder
as the clinical target volume (CTV) [24]. However, most
of the available data were reported in prostate cancer
patients in whom the bladder was contoured as an
OAR, and thus there could be some biases, such as
patient selection, gender, and preparation protocol before
each treatment. The aim of the present study was to
analyze and evaluate the inter-observer contouring
uncertainties of bladder boundary delineation on CBCT
images in a prospective fashion.Figure 3 The standard deviation (SD) of the center of mass (COM) dis
horizontal solid line indicates the root mean square (RMS) of the overall SD
indicate the σ of the female bladders and male bladders, respectively.There is no general consensus in the literature regarding
the analysis of inter-observer variability in delineation.
Recently, Fotina et al. reported common relationships
between the different parameters reported and discussed
the minimal set of parameters needed for “full description”
of variability in delineation. They concluded that a combin-
ation of descriptive statistics, overlapping measurements,
and statistical measures of agreement was required for a
full reporting [19]. We selected the COV and ICC(2,k) as
parameters of descriptive statistics and statistical measures
of agreement, and the CIgen as an indication of overlapping
measurements as appropriate tool independent fromplacement value of the structure along each direction. The
(σ) of the bladders and prostates. The dotted line and dashed line
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Kouwenhoven et al. [18].
The results of this study were in accordance with those
of previous reports. Lütgendorf-Caucig et al. reported that
the mean COV and CIgen for the bladder on CBCT imaging
was 0.06 ± 0.02 and 0.82 ± 0.05, and RMS (σ) of the COM
displacement for the bladder was smaller than 1mm in all
directions. While for the prostate, the mean COV and
CIgen was 0.24 ± 0.07 and 0.57 ± 0.09 and σ of the COM
displacement was 0.4 mm (LR), 1.1 mm (AP), and 1.7 mm
(CC), respectively [14]. Weiss et al. reported the patient-
averaged COV was 0.08 for the bladder and 0.19 for the
prostate [15]. White et al. reported the average standard
deviation for COM displacements of the prostate was 0.7
mm (LR), 1.8 mm (AP), and 2.8 mm (CC) [25].
The limitation of this study is that the number of
patients and observers was small especially when we
separated them by gender. We could not find an apparent
difference between males and females in either the mean
bladder COV or the mean CIgen in our analysis but it is
not conclusive. Regarding the σ of COM displacement,
the significance of difference between males and females
could not be statistically analyzed, but σ along each direc-
tion was quite small (equal to or less than 1 mm).
Conclusions
Inter-observer variability for bladder delineation on CBCT
images was substantially small regardless of gender. We
believe that our results support the applicability of CBCT
in adaptive radiotherapy for bladder cancer.
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